IRIS
BARBANTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.568
AS - Asia 11.636
EU - Europa 8.663
SA - Sud America 1.759
AF - Africa 148
OC - Oceania 16
Totale 36.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.377
HK - Hong Kong 7.919
IE - Irlanda 5.958
SG - Singapore 2.187
BR - Brasile 1.446
GB - Regno Unito 936
CN - Cina 413
CH - Svizzera 409
VN - Vietnam 394
FI - Finlandia 331
IT - Italia 324
DE - Germania 238
TR - Turchia 159
AR - Argentina 122
IN - India 108
FR - Francia 99
BD - Bangladesh 80
CA - Canada 78
MX - Messico 78
EC - Ecuador 53
IQ - Iraq 53
NL - Olanda 52
PL - Polonia 50
CO - Colombia 46
EE - Estonia 41
ID - Indonesia 41
RU - Federazione Russa 39
ZA - Sudafrica 38
CZ - Repubblica Ceca 36
UZ - Uzbekistan 33
PK - Pakistan 31
KR - Corea 28
ES - Italia 26
MA - Marocco 25
JP - Giappone 24
SE - Svezia 24
PY - Paraguay 23
AT - Austria 22
PH - Filippine 20
EG - Egitto 19
UA - Ucraina 19
VE - Venezuela 19
CL - Cile 18
UY - Uruguay 18
KE - Kenya 17
SA - Arabia Saudita 15
AU - Australia 14
MY - Malesia 13
IL - Israele 11
IR - Iran 11
JO - Giordania 11
ET - Etiopia 10
NP - Nepal 10
PE - Perù 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
BG - Bulgaria 8
DZ - Algeria 8
TH - Thailandia 8
TW - Taiwan 8
JM - Giamaica 6
KZ - Kazakistan 6
LT - Lituania 6
LV - Lettonia 6
CR - Costa Rica 5
LY - Libia 5
OM - Oman 5
AM - Armenia 4
AO - Angola 4
BE - Belgio 4
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HN - Honduras 4
KG - Kirghizistan 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BB - Barbados 3
CY - Cipro 3
HU - Ungheria 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
TG - Togo 3
TT - Trinidad e Tobago 3
UG - Uganda 3
KH - Cambogia 2
LB - Libano 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
GD - Grenada 1
Totale 36.771
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.918
Dallas 6.295
Dublin 5.920
Ashburn 1.553
San Jose 1.325
Singapore 1.058
London 835
Boardman 807
The Dalles 481
Chicago 468
Santa Clara 444
Zurich 406
Helsinki 318
Washington 197
Ho Chi Minh City 138
São Paulo 127
Istanbul 115
Los Angeles 110
Hanoi 87
Assago 76
Munich 73
Beijing 68
Rio de Janeiro 54
Council Bluffs 50
New York 43
Warsaw 43
Hillsboro 42
San Francisco 42
Belo Horizonte 38
Milan 38
Orem 36
Frankfurt am Main 35
Montreal 33
Amsterdam 28
Seattle 28
Tashkent 28
Chennai 27
Brasília 26
Brooklyn 26
Mexico City 26
Seoul 25
Porto Alegre 22
Brno 21
Guayaquil 21
Rome 20
Salvador 20
Atlanta 18
Catania 18
Johannesburg 18
Stockholm 18
Manchester 17
Montevideo 17
Boston 16
Curitiba 16
Da Nang 16
Haiphong 16
Nairobi 16
Quito 16
Shanghai 15
Campinas 14
Hải Dương 14
Mumbai 14
Olomouc 14
Tokyo 14
Falkenstein 13
Baghdad 12
Buenos Aires 12
Dhaka 12
Duque de Caxias 12
Goiânia 12
Guarulhos 12
Thái Bình 12
Amman 11
Fortaleza 11
Phoenix 11
Cipolletti 10
Reston 10
Ribeirão Preto 10
Thái Nguyên 10
Turku 10
Addis Ababa 9
Bexley 9
Casablanca 9
Clifton 9
Düsseldorf 9
Erbil 9
Genoa 9
Guangzhou 9
Jeddah 9
Karachi 9
Lahore 9
Medellín 9
Piscataway 9
Toronto 9
Baku 8
Cairo 8
Caracas 8
Jakarta 8
Joinville 8
Manaus 8
Totale 30.232
Salva come PNG Salva come JPEG
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 2.465
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.177
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 972
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 969
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 721
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 654
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 566
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 554
Predicting neocommissural orientation during TAVI workup 509
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 495
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 443
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 386
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 380
Le nuove frontiere della cardiologia interventistica strutturale 356
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 145
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 140
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 138
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 137
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 131
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 131
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 128
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 123
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 122
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 121
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 121
Transcatheter mitral valve implantation: CardiAQ 120
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 114
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 113
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study 112
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 110
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 109
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 108
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 108
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 107
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 107
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 106
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 106
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 103
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases 102
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 101
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 99
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 99
Managing complications after transcatheter aortic valve implantation 98
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 98
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 98
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 97
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 96
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 95
Early detection of transcatheter heart valve dysfunction 94
[First results from the OBSERVANT II study: clinical characteristics of patients with aortic stenosis undergoing transcatheter treatment with new generation devices] 94
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 93
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 93
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 93
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 92
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 92
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 91
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 91
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation 91
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 88
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 88
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 88
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 88
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 88
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 87
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 87
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 86
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 86
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 85
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 85
Cerebral embolization during transcatheter aortic valve implantation 85
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 85
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 85
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 84
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 84
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 84
Bioprosthetic valves for transcatheter aortic valve replacement 83
The Helio transcatheter aortic dock for patients with aortic regurgitation 83
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 83
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 83
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 83
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 83
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 82
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 82
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 82
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 82
Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes 82
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 81
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 81
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 81
Management of severe stenosis controversies and promises 81
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 80
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 80
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 80
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 80
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 80
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 80
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 80
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 80
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 79
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 79
Totale 18.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.818
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/202614.032 870 3.391 3.663 1.212 323 469 1.512 975 991 626 0 0
Totale 37.257